Coldstream Laboratories appoints vp of manufacturing

Dr Vickie Hall takes responsibility for manufacturing, facilities and warehouse operations

Coldstream Laboratories, a US provider of drug product research and manufacturing services, has named Dr Vickie Hall as vice president of manufacturing.

In her new position, Hall will assume responsibility of Coldstream's manufacturing, facilities, and warehouse operations in Lexington, Kentucky.

Hall brings to Coldstream more than 20 years of experience in managing research, product development, manufacturing and operations for vaccines and pharmaceuticals. Most recently, she served as executive director of manufacturing science and technology at Ben Venue Laboratories, a subsidiary of the Boehringer Ingelheim Corporation.

You may also like

Manufacturing

Piramal acquires Coldstream Laboratories for US$30.65m

Kentucky based CDMO specialises in sterile liquid and freeze-dried parenterals and injectables
Research & Development

Jabil and Kymanox collaboration to deliver end-to-end development, regulatory and manufacturing solutions

Jabil and Kymanox are partnering to combine their regulatory, technical, and manufacturing expertise to help life science companies streamline development and bring complex therapies to market faster
Research & Development

Piramal Pharma Solutions formalises partnership with IntoCell

Piramal Pharma Solutions has joined forces with IntoCell to broaden its bioconjugates offering and support innovation in the field
Manufacturing

Frontline innovation: dispatches from the show floor at CPHI Frankfurt (part III)

The third instalment from the CPHI Frankfurt show floor explores practical approaches and fresh perspectives on scale-up, tech transfer, and manufacturing innovation across the pharmaceutical sector
Research & Development

Immunology CRO reports shift to autoimmunity projects

RoukenBio reports a sharp rise in autoimmunity drug development projects and an almost 50% decrease in immuno-oncology (I-O) studies, showcasing the shift in drug development trends
Research & Development

Merck partners with Promega to advance 3D cell drug discovery technologies

Partnership combines Merck’s chemistry and organoid expertise with Promega’s assay technologies
Manufacturing

Streamlining bioconjugation for next-generation ADC development

Abzena’s proprietary ThioBridge™ technology delivers precision, scalability, and enhanced stability for antibody-drug conjugates
Subscribe now